EQ · Equillium, Inc. · Executive Compensation
Market Cap
$90.04M
Shares
63.41M
Volume · Oct 28
227.36K
Avg daily vol (3M)
579.9K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Bruce D. Steel | Chief Executive Officer | $4,255,248 |
| Stephen Connelly | President and Chief Scientific Officer | $2,701,826 |
| Christine Zedelmayer | Chief Operating Officer | $2,102,076 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Bruce D. Steel | President and Chief Executive Officer | $648,392 |
| Stephen Connelly | Chief Scientific Officer | $519,427 |
| Christine Zedelmayer | Chief Operating Officer | $506,237 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Bruce D. Steel | President and Chief Executive Officer | $1,348,215 |
| Stephen Connelly | Chief Scientific Officer | $827,254 |
| Christine Zedelmayer | Chief Operating Officer | $785,506 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Bruce D. Steel | President and Chief Executive Officer | $1,678,838 |
| Stephen Connelly | Chief Scientific Officer | $918,788 |
| Christine Zedelmayer | Senior Vice President, Chief Operating Officer | $900,938 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Dolca Thomas | M.D. ^^ Former Executive Vice President, Research and Development and Chief Medical Officer | $2,336,404 |
| Bruce D. Steel | President and Chief Executive Officer | $1,552,218 |
| Stephen Connelly | Chief Scientific Officer | $895,240 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Bruce D. Steel | President and Chief Executive Officer | $782,306 |
| Stephen Connelly | Chief Scientific Officer | $639,807 |
| Krishna R. Polu | M.D.^^ Former Executive Vice President, Research and Development and Chief Medical Officer | $612,000 |
| Dolca Thomas | M.D. ^^ Former Executive Vice President, Research and Development and Chief Medical Officer | — |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Krishna R. Polu | M.D.^^ Former Executive Vice President, Research and Development and Chief Medical Officer | $1,508,122 |
| Bruce D. Steel | President and Chief Executive Officer | $1,358,868 |
| Stephen Connelly | Ph.D.^^ Chief Scientific Officer | $484,844 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Krishna R. Polu | Executive Vice President, Research and Development and Chief Medical Officer | $2,335,283 |
| Bruce D. Steel | President and Chief Executive Officer; former Chief Business Offer | $295,313 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Mark Pruzanski, M.D. | chairperson of the Compensation Committee | Appointed | 2025-10-06 |
| Bala Manian, Ph.D. | Director | Resigned | 2025-10-06 |
| Stephen Connelly, Ph.D. | Director | Resigned | 2025-10-06 |
| Barbara Troupin, M.D. | Class I director | Appointed | 2025-05-22 |
| Bala S. Manian, Ph.D. | Class I director | Appointed | 2025-05-22 |
| Stephen Connelly, Ph.D. | Class I director | Appointed | 2025-05-22 |
| Peter Colabuono | Class II director | Appointed | 2024-12-12 |
| Barbara Troupin, M.D. | member of the Company's Audit Committee | Appointed | 2024-12-12 |
| Yu (Katherine) Xu, Ph.D. | member of the Board of Directors | Resigned | 2024-12-12 |
| Penny Tom | principal accounting officer | Appointed | 2024-03-08 |
Leadership
- Bruce D. Steel CEO
- Daniel M. Bradbury Chairman
- Christine Zedelmayer COO
- Penny Tom Chief Accounting Officer
- Bala S. Manian, Ph.D. Board Member
- Barbara Troupin Board Member
- Barbara Troupin, M.D. Board Member
- Peter Colabuono Board Member
- Stephen Connelly, Ph.D. Board Member
- Yu (Katherine) Xu Board Member